(061863.TW)

Compare

1.8000

0.0000

(0.00%)

At close: December 17 at 9:23:36 AM GMT+8

Nvidia is on a collision course with a $5 trillion valuation: Analyst

If Nvidia were an all-night party, this would be 10 p.m., argues Wedbush analyst Dan Ives.

Yahoo Finance 18 minutes ago

NVDA
Big Tech is dominating the market once again — and that's probably just fine: Morning Brief

December is shaping up to be a tale of two markets.

Yahoo Finance 2 hours ago

GOOG

AMZN

QQQ
Fed decision, Micron earnings, housing data: What to Watch

Hosts Julie Hyman and Josh Lipton detail the top market news to watch for tomorrow, Wednesday, December 18. Investors are focused on the Federal Reserve as the Federal Open Market Committee (FOMC) Meeting concludes tomorrow. The central bank is set to announce its interest rate decision at 2 p.m. ET, and market participants are expecting a potential 25-basis-point cut to interest rates. On the earnings front, Wall Street will scrutinize quarterly reports from Micron Technology (MU), Lennar (LEN), General Mills (GIS), and Birkenstock (BIRK). Additionally, monthly Housing Starts and Building Permits data will provide crucial insights into the current state of the housing market. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Angel Smith

Yahoo Finance Video 13 hours ago

MU

LEN

LEN-B
Nvidia stock slides amid AI spending slowdown fears, increased competition

Nvidia stock sank more than 2% early Tuesday, putting the AI chipmaker down 14% from its record high closing price of $148.88 in early November.

Yahoo Finance 16 hours ago

AVGO

AMZN

NVDA
Broadcom stock eases on post-earnings rally as Nvidia tumbles

Broadcom (AVGO) is letting up some of its post-earnings steam, though the AI chip stock is still up by 34% over the past five trading day's and 42% over the past month. The Morning Brief's Seana Smith and Brad Smith compare Broadcom's trading patterns as of late with that of Nvidia's (NVDA), as the latter slips further from its all-time high from November 7 and enters correction territory this week. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 22 hours ago

AVGO

NVDA
Nissan-Honda merger would not bring quick fixes, S&P says

While the potential deal would result in a $54 billion automotive company, the world's third largest, any benefits for its credit outlook would come with a delay, they wrote in a research note. "We ... believe it will be difficult for them to produce significant effects quickly through expanding the scope of their collaboration to include batteries, software, and autonomous driving," S&P analysts said, but added the eventual impact on their creditworthiness would be significant. A merger would likely have a negative impact Honda's standalone credit outlook, while it should positively affect that of Nissan, they added.

Reuters 22 minutes ago

HMC

NSANY
Corvus Pharma Says Data From Atopic Dermatitis Study Shows Favorable Safety Profile; Shares Fall Pre-Bell

Corvus Pharmaceuticals (CRVS) said Wednesday that interim results from a phase 1 trial of its experi

PREMIUM
MT Newswires 27 minutes ago

CRVS
Rezolve Ai Announces $49 Million Equity Conversion by Leading Investors

Equity conversion strengthens financial position and accelerates global expansion in the $30 trillion retail market.NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven retail innovation, and its leading investors have entered into a series of transactions agreeing to the conversion of $49 million of the outstanding convertible loan note into equity. The debt subject to conversion was issued pursuant to the secured convertible loan note instrument d

GlobeNewswire 28 minutes ago

RZLV

RZLVW
General Mills Beats On Q2 Earnings, Stock Slumps On Lackluster Outlook

General Mills, Inc. (NYSE:GIS) shares are trading lower in the premarket session on Wednesday. The company reported second-quarter adjusted earnings per share of $1.40, beating the street view of $1.22. Quarterly sales of $5.24 billion beat the analyst consensus estimate of $5.14 billion. Quarterly sales were up 2%, driven by higher pound volume, while organic net sales increased 1%. Gross margin was up 250 basis points to 36.9%, driven primarily by Holistic Margin Management cost savings and fa

Benzinga 32 minutes ago

GIS
Jabil tops first-quarter estimates on data center infrastructure demand

Electronic components maker Jabil beat first-quarter profit and revenue estimates on Wednesday, driven by increased demand for data center infrastructure. Shares of the company were up 10% in premarket trading. Jabil, a key supplier to Apple, makes electronic components, including circuit board assemblies and systems for automotive, cloud services, commercial drones, trucks and buses.

Reuters 33 minutes ago

JBL
General Mills Lowers Profit Outlook on Price Cuts

(Bloomberg) -- Cheerios maker General Mills Inc. lowered its profit outlook for fiscal 2025 in order to invest in price reductions to drive sales.Most Read from BloombergHow California Sees the World, and ItselfThe company now expects adjusted earnings per share to range between a decline of 3% to 1%, compared with a previous range of down 1% to up 1%.The shares fell 6% before the start of regular trading on Wednesday in New York. The stock had risen 1.2% so far this year through Tuesday’s close

Bloomberg 55 minutes ago

GIS

^GSPC
Toyota Motors: Facing Challenges, but Strong EV Future Ahead

Toyota's electrification progress is notable, but short-term challenges remain

GuruFocus.com 57 minutes ago

TM

NSANY

TSLA
Jabil: Fiscal Q1 Earnings Snapshot

The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.87 per share. The electronics manufacturer posted revenue of $6.99 billion in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $6.6 billion.

Associated Press Finance 1 hour ago

JBL
Is Jabil Inc. (NYSE:JBL) Trading At A 49% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Jabil fair value estimate is US$265 Current share price of...

Simply Wall St. 1 hour ago

JBL
5 Things to Know Before the Stock Market Opens

News of the day for Dec. 18, 2024

Investopedia 1 hour ago

MU

NVDA

^DJI
Jabil Posts Strong First Quarter Results

ST. PETERSBURG, Fla., December 18, 2024--Today, Jabil Inc. (NYSE: JBL), reported preliminary, unaudited financial results for its first quarter of fiscal year 2025.

Business Wire 1 hour ago

JBL
General Mills Stock Falls as Earnings Outlook Is Lowered

General Mills stock tumbled in premarket trading Wednesday after the packaged-food company reported better-than-expected fiscal second-quarter earnings but lowered its fiscal-year outlook. General Mills reported net sales of $5.2 billion for the quarter ended Nov. 24, a 2% increase from the prior year and narrowly beating the FactSet consensus estimate of 5.1 billion. Shares of the company fell 3.7% to $63.50, however, after General Mills slashed its guidance for the fiscal year, citing “an uncertain macroeconomic backdrop for consumers across its core markets.”

Barrons.com 1 hour ago

GIS
Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profile Data includes complete results from cohort 1 and initial results from cohort 2 Early exercise of common stock warrants from stockholder generates cash proceeds of approximately $12.7 million Company to host conference call and webcast today at 8:00 a.m. ET / 5:00 a.m. PT BURLINGAME, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical compan

GlobeNewswire 1 hour ago

CRVS
Nvidia Stock Rises After Slump. Don’t Call It a Comeback Yet.

The chip maker's shares have tumbled 12% since early November as a number of factors have sparked concerns among investors.

Barrons.com 1 hour ago

NVDA

AVGO

GOOG
Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies

- Improvements Across Measures of Behavior, Function, Cognition and Movement - - Expediting Plans to Advance CT1812 into Late-Stage Trials - - Full Results to be Presented at International Lewy Body Dementia Conference (ILBDC) - - Cognition Therapeutics and Dr. Galvin, a Principal Investigator, Will Host a Conference Call at 8am ET on December 18 to Review the Topline Data - PURCHASE, N.Y., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company de

GlobeNewswire 1 hour ago

CGTX

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

(061863.TW)

Related News

Nvidia is on a collision course with a $5 trillion valuation: Analyst

Big Tech is dominating the market once again — and that's probably just fine: Morning Brief

Fed decision, Micron earnings, housing data: What to Watch

Nvidia stock slides amid AI spending slowdown fears, increased competition

Broadcom stock eases on post-earnings rally as Nvidia tumbles

Nissan-Honda merger would not bring quick fixes, S&P says

Corvus Pharma Says Data From Atopic Dermatitis Study Shows Favorable Safety Profile; Shares Fall Pre-Bell

Rezolve Ai Announces $49 Million Equity Conversion by Leading Investors

General Mills Beats On Q2 Earnings, Stock Slumps On Lackluster Outlook

Jabil tops first-quarter estimates on data center infrastructure demand

General Mills Lowers Profit Outlook on Price Cuts

Toyota Motors: Facing Challenges, but Strong EV Future Ahead

Jabil: Fiscal Q1 Earnings Snapshot

Is Jabil Inc. (NYSE:JBL) Trading At A 49% Discount?

5 Things to Know Before the Stock Market Opens

Jabil Posts Strong First Quarter Results

General Mills Stock Falls as Earnings Outlook Is Lowered

Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Nvidia Stock Rises After Slump. Don’t Call It a Comeback Yet.

Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies